By adopting strategies that target the tumor vasculature, tumor cells and cancer-associated fibroblasts, molecular precision in PDP hold significant potential in further improving the diagnostic accuracy of molecular probes, such as Cet-IRDye800, for P-IGS. Here, PDP1 is linked to cancer.